Gilead closes in on second CAR-T approval in US | GILD Message Board Posts

Gilead Sciences, Inc.

  GILD website

GILD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  11909 of 11927  at  2/15/2020 9:56:06 PM  by

spaddy


 In response to msg 11908 by  jerrykrause
view thread

Re: Gilead closes in on second CAR-T approval in US

 Wonder if they could convince the FDA to use this new manufacturing method to do a second line trial in DLBCL instead of its original Yescarta?
Or are they running trials with both?
 
There must be 20 CD19 CART trials going on, all fighting for last line indications while GILD moves up the chain one step ahead to second and first line.
Lots of those small early stage companies wont make money from their CD19 trials, but will need a buyout after spending all that cash for proof of concept.
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 166
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...